In a study published by Nicole Buerki et al. in 2012, the authors concluded that the cumulative risk for developing BC in MLH1/MSH2 carriers was 5.2% until age 70 years, with a higher risk for MSH2 PV carriers, which can reach up to 10.1% [48]. Here, MSH2 is linked to breast cancer.